ID AIM1_ARATH Reviewed; 721 AA. AC Q9ZPI6; DT 30-NOV-2010, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 02-SEP-2026, entry version 178. DE RecName: Full=Peroxisomal fatty acid beta-oxidation multifunctional protein AIM1 {ECO:0000305}; DE AltName: Full=Protein ABNORMAL INFLORESCENCE MERISTEM 1 {ECO:0000303|PubMed:10521521}; DE Short=AtAIM1 {ECO:0000303|PubMed:10521521}; DE Includes: DE RecName: Full=Enoyl-CoA hydratase/3-2-trans-enoyl-CoA isomerase/3-hydroxybutyryl-CoA epimerase; DE EC=4.2.1.17 {ECO:0000269|PubMed:10521521, ECO:0000269|PubMed:20463021}; DE EC=5.1.2.3 {ECO:0000305}; DE EC=5.3.3.8 {ECO:0000305}; DE Includes: DE RecName: Full=3-hydroxyacyl-CoA dehydrogenase; DE EC=1.1.1.35 {ECO:0000269|PubMed:20463021}; GN Name=AIM1; OrderedLocusNames=At4g29010; ORFNames=F19B15.40; OS Arabidopsis thaliana (Mouse-ear cress). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae; OC rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis. OX NCBI_TaxID=3702; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, RP BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND DISRUPTION RP PHENOTYPE. RX PubMed=10521521; DOI=10.1105/tpc.11.10.1911; RA Richmond T.A., Bleecker A.B.; RT "A defect in beta-oxidation causes abnormal inflorescence development in RT Arabidopsis."; RL Plant Cell 11:1911-1924(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=cv. Columbia; RX PubMed=10617198; DOI=10.1038/47134; RA Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G., Pohl T., RA Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N., Harris B., RA Ansorge W., Brandt P., Grivell L.A., Rieger M., Weichselgartner M., RA de Simone V., Obermaier B., Mache R., Mueller M., Kreis M., Delseny M., RA Puigdomenech P., Watson M., Schmidtheini T., Reichert B., Portetelle D., RA Perez-Alonso M., Boutry M., Bancroft I., Vos P., Hoheisel J., RA Zimmermann W., Wedler H., Ridley P., Langham S.-A., McCullagh B., RA Bilham L., Robben J., van der Schueren J., Grymonprez B., Chuang Y.-J., RA Vandenbussche F., Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., RA Defoor E., Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M., RA Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W., Mooijman P., RA Klein Lankhorst R., Rose M., Hauf J., Koetter P., Berneiser S., Hempel S., RA Feldpausch M., Lamberth S., Van den Daele H., De Keyser A., Buysshaert C., RA Gielen J., Villarroel R., De Clercq R., van Montagu M., Rogers J., RA Cronin A., Quail M.A., Bray-Allen S., Clark L., Doggett J., Hall S., RA Kay M., Lennard N., McLay K., Mayes R., Pettett A., Rajandream M.A., RA Lyne M., Benes V., Rechmann S., Borkova D., Bloecker H., Scharfe M., RA Grimm M., Loehnert T.-H., Dose S., de Haan M., Maarse A.C., Schaefer M., RA Mueller-Auer S., Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., RA Herzl A., Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E., RA Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R., Schnabl S., RA Hiller R., Schmidt W., Lecharny A., Aubourg S., Chefdor F., Cooke R., RA Berger C., Monfort A., Casacuberta E., Gibbons T., Weber N., Vandenbol M., RA Bargues M., Terol J., Torres A., Perez-Perez A., Purnelle B., Bent E., RA Johnson S., Tacon D., Jesse T., Heijnen L., Schwarz S., Scholler P., RA Heber S., Francs P., Bielke C., Frishman D., Haase D., Lemcke K., RA Mewes H.-W., Stocker S., Zaccaria P., Bevan M., Wilson R.K., RA de la Bastide M., Habermann K., Parnell L., Dedhia N., Gnoj L., Schutz K., RA Huang E., Spiegel L., Sekhon M., Murray J., Sheet P., Cordes M., RA Abu-Threideh J., Stoneking T., Kalicki J., Graves T., Harmon G., RA Edwards J., Latreille P., Courtney L., Cloud J., Abbott A., Scott K., RA Johnson D., Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K., RA Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W., RA Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D., Du H., RA Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C., Antonoiu B., RA Zidanic M., Strong C., Sun H., Lamar B., Yordan C., Ma P., Zhong J., RA Preston R., Vil D., Shekher M., Matero A., Shah R., Swaby I.K., RA O'Shaughnessy A., Rodriguez M., Hoffman J., Till S., Granat S., Shohdy N., RA Hasegawa A., Hameed A., Lodhi M., Johnson A., Chen E., Marra M.A., RA Martienssen R., McCombie W.R.; RT "Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana."; RL Nature 402:769-777(1999). RN [3] RP GENOME REANNOTATION. RC STRAIN=cv. Columbia; RX PubMed=27862469; DOI=10.1111/tpj.13415; RA Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S., RA Town C.D.; RT "Araport11: a complete reannotation of the Arabidopsis thaliana reference RT genome."; RL Plant J. 89:789-804(2017). RN [4] RP GENOME REANNOTATION. RC STRAIN=cv. Columbia; RG The Arabidopsis Information Resource (TAIR); RT "Community-consensus reference genome of Arabidopsis thaliana Col-0."; RL Submitted (FEB-2026) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=cv. Columbia; RX PubMed=14593172; DOI=10.1126/science.1088305; RA Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M., RA Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G., RA Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L., RA Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C., RA Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J., RA Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A., RA Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C., RA Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X., RA Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M., RA Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K., RA Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A., RA Ecker J.R.; RT "Empirical analysis of transcriptional activity in the Arabidopsis RT genome."; RL Science 302:842-846(2003). RN [6] RP FUNCTION. RX PubMed=17544464; DOI=10.1016/j.phytochem.2007.04.024; RA Delker C., Zolman B.K., Miersch O., Wasternack C.; RT "Jasmonate biosynthesis in Arabidopsis thaliana requires peroxisomal beta- RT oxidation enzymes--additional proof by properties of pex6 and aim1."; RL Phytochemistry 68:1642-1650(2007). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=17951448; DOI=10.1105/tpc.107.050989; RA Reumann S., Babujee L., Ma C., Wienkoop S., Siemsen T., Antonicelli G.E., RA Rasche N., Lueder F., Weckwerth W., Jahn O.; RT "Proteome analysis of Arabidopsis leaf peroxisomes reveals novel targeting RT peptides, metabolic pathways, and defense mechanisms."; RL Plant Cell 19:3170-3193(2007). RN [8] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=20463021; DOI=10.1074/jbc.m110.106005; RA Arent S., Christensen C.E., Pye V.E., Noergaard A., Henriksen A.; RT "The multifunctional protein in peroxisomal beta-oxidation: structure and RT substrate specificity of the Arabidopsis thaliana protein MFP2."; RL J. Biol. Chem. 285:24066-24077(2010). RN [9] RP FUNCTION. RX PubMed=24254312; DOI=10.1104/pp.113.229807; RA Bussell J.D., Reichelt M., Wiszniewski A.A., Gershenzon J., Smith S.M.; RT "Peroxisomal ATP-binding cassette transporter COMATOSE and the RT multifunctional protein abnormal INFLORESCENCE MERISTEM are required for RT the production of benzoylated metabolites in Arabidopsis seeds."; RL Plant Physiol. 164:48-54(2014). CC -!- FUNCTION: Involved in peroxisomal fatty acid beta-oxidation. Required CC for wound-induced jasmonate biosynthesis. Possesses enoyl-CoA hydratase CC activity against short chain substrates (C4-C6) and 3-hydroxyacyl-CoA CC dehydrogenase activity against chains of variable sizes (C6-C16) CC (PubMed:10521521, PubMed:17544464, PubMed:20463021). Possesses CC cinnamoyl-CoA hydratase activity and is involved in the peroxisomal CC beta-oxidation pathway for the biosynthesis of benzoic acid (BA). CC Required for the accumulation in seeds of benzoylated glucosinolates CC (BGs) and substituted hydroxybenzoylated choline esters, which are BA- CC containing secondary metabolites. Required for salicylic acid (SA) in CC seeds (PubMed:24254312). {ECO:0000269|PubMed:10521521, CC ECO:0000269|PubMed:17544464, ECO:0000269|PubMed:20463021, CC ECO:0000269|PubMed:24254312}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a (3S)-3-hydroxyacyl-CoA = a (2E)-enoyl-CoA + H2O; CC Xref=Rhea:RHEA:16105, ChEBI:CHEBI:15377, ChEBI:CHEBI:57318, CC ChEBI:CHEBI:58856; EC=4.2.1.17; CC Evidence={ECO:0000269|PubMed:10521521, ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 4-saturated-(3S)-3-hydroxyacyl-CoA = a (3E)-enoyl-CoA + H2O; CC Xref=Rhea:RHEA:20724, ChEBI:CHEBI:15377, ChEBI:CHEBI:58521, CC ChEBI:CHEBI:137480; EC=4.2.1.17; CC Evidence={ECO:0000269|PubMed:10521521, ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-3-hydroxybutanoyl-CoA = (2E)-butenoyl-CoA + H2O; CC Xref=Rhea:RHEA:26558, ChEBI:CHEBI:15377, ChEBI:CHEBI:57316, CC ChEBI:CHEBI:57332; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:26560; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxyoctanoyl-CoA = (2E)-octenoyl-CoA + H2O; CC Xref=Rhea:RHEA:31199, ChEBI:CHEBI:15377, ChEBI:CHEBI:62242, CC ChEBI:CHEBI:62617; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31201; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-3-hydroxydodecanoyl-CoA = (2E)-dodecenoyl-CoA + H2O; CC Xref=Rhea:RHEA:31075, ChEBI:CHEBI:15377, ChEBI:CHEBI:57330, CC ChEBI:CHEBI:62558; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31077; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxytetradecanoyl-CoA = (2E)-tetradecenoyl-CoA + H2O; CC Xref=Rhea:RHEA:31171, ChEBI:CHEBI:15377, ChEBI:CHEBI:61405, CC ChEBI:CHEBI:62614; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31173; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxyhexanoyl-CoA = (2E)-hexenoyl-CoA + H2O; CC Xref=Rhea:RHEA:30547, ChEBI:CHEBI:15377, ChEBI:CHEBI:62075, CC ChEBI:CHEBI:62077; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:30549; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a (3Z)-enoyl-CoA = a 4-saturated (2E)-enoyl-CoA; CC Xref=Rhea:RHEA:45900, ChEBI:CHEBI:85097, ChEBI:CHEBI:85489; CC EC=5.3.3.8; Evidence={ECO:0000305}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a (3E)-enoyl-CoA = a 4-saturated (2E)-enoyl-CoA; CC Xref=Rhea:RHEA:45228, ChEBI:CHEBI:58521, ChEBI:CHEBI:85097; CC EC=5.3.3.8; Evidence={ECO:0000305}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-3-hydroxybutanoyl-CoA = (3R)-3-hydroxybutanoyl-CoA; CC Xref=Rhea:RHEA:21760, ChEBI:CHEBI:57315, ChEBI:CHEBI:57316; CC EC=5.1.2.3; Evidence={ECO:0000305}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a (3S)-3-hydroxyacyl-CoA + NAD(+) = a 3-oxoacyl-CoA + NADH + CC H(+); Xref=Rhea:RHEA:22432, ChEBI:CHEBI:15378, ChEBI:CHEBI:57318, CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:90726; EC=1.1.1.35; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-3-hydroxybutanoyl-CoA + NAD(+) = acetoacetyl-CoA + NADH + CC H(+); Xref=Rhea:RHEA:30799, ChEBI:CHEBI:15378, ChEBI:CHEBI:57286, CC ChEBI:CHEBI:57316, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; CC Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30800; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxyhexanoyl-CoA + NAD(+) = 3-oxohexanoyl-CoA + NADH + CC H(+); Xref=Rhea:RHEA:31143, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945, ChEBI:CHEBI:62075, ChEBI:CHEBI:62418; CC Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31144; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxyoctanoyl-CoA + NAD(+) = 3-oxooctanoyl-CoA + NADH + CC H(+); Xref=Rhea:RHEA:31195, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945, ChEBI:CHEBI:62617, ChEBI:CHEBI:62619; CC Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31196; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-3-hydroxydodecanoyl-CoA + NAD(+) = 3-oxododecanoyl-CoA + CC NADH + H(+); Xref=Rhea:RHEA:31179, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62558, CC ChEBI:CHEBI:62615; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31180; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(3S)-hydroxytetradecanoyl-CoA + NAD(+) = 3-oxotetradecanoyl- CC CoA + NADH + H(+); Xref=Rhea:RHEA:31167, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62543, CC ChEBI:CHEBI:62614; Evidence={ECO:0000269|PubMed:20463021}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31168; CC Evidence={ECO:0000269|PubMed:20463021}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=115 uM for crotonyl-CoA {ECO:0000269|PubMed:10521521}; CC -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10521521}. CC -!- DOMAIN: The epimerase and isomerase activities are contained in the N- CC terminal region while the dehydrogenase activity is in the C-terminal CC region. {ECO:0000250}. CC -!- DISRUPTION PHENOTYPE: Reduced rosette size, twisted leaves, and CC abnormal and sterile flowers. {ECO:0000269|PubMed:10521521}. CC -!- SIMILARITY: In the N-terminal section; belongs to the enoyl-CoA CC hydratase/isomerase family. {ECO:0000305}. CC -!- SIMILARITY: In the central section; belongs to the 3-hydroxyacyl-CoA CC dehydrogenase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF123253; AAD18041.1; -; Genomic_DNA. DR EMBL; AL078470; CAB43915.1; -; Genomic_DNA. DR EMBL; AL161574; CAB79659.1; -; Genomic_DNA. DR EMBL; CP002687; AEE85572.1; -; Genomic_DNA. DR EMBL; OZ408686; CAO7049146.1; -; Genomic_DNA. DR EMBL; AY059815; AAL24297.1; -; mRNA. DR EMBL; AY072072; AAL59895.1; -; mRNA. DR EMBL; AY096659; AAM20293.1; -; mRNA. DR PIR; T08956; T08956. DR RefSeq; NP_194630.1; NM_119045.5. DR AlphaFoldDB; Q9ZPI6; -. DR SMR; Q9ZPI6; -. DR BioGRID; 14309; 8. DR FunCoup; Q9ZPI6; 2624. DR STRING; 3702.Q9ZPI6; -. DR SwissLipids; SLP:000000866; -. DR iPTMnet; Q9ZPI6; -. DR MetOSite; Q9ZPI6; -. DR PaxDb; 3702-Q9ZPI6; -. DR ProteomicsDB; 244919; -. DR GeneID; 829022; -. DR KEGG; ath:AT4G29010; -. DR Araport; AT4G29010; -. DR TAIR; AT4G29010; AIM1. DR eggNOG; KOG1683; Eukaryota. DR HOGENOM; CLU_009834_16_3_1; -. DR InParanoid; Q9ZPI6; -. DR OMA; DPLFWKP; -. DR PhylomeDB; Q9ZPI6; -. DR BioCyc; MetaCyc:AT4G29010-MONOMER; -. DR SABIO-RK; Q9ZPI6; -. DR UniPathway; UPA00659; -. DR CD-CODE; 4299E36E; Nucleolus. DR PRO; PR:Q9ZPI6; -. DR Proteomes; UP000006548; Chromosome 4. DR ExpressionAtlas; Q9ZPI6; baseline and differential. DR GO; GO:0005737; C:cytoplasm; ISM:TAIR. DR GO; GO:0005777; C:peroxisome; IDA:TAIR. DR GO; GO:0009505; C:plant-type cell wall; HDA:TAIR. DR GO; GO:0005886; C:plasma membrane; HDA:TAIR. DR GO; GO:0009506; C:plasmodesma; HDA:TAIR. DR GO; GO:0120092; F:(2E)-butenoyl-CoA hydratase activity; IEA:RHEA. DR GO; GO:0003857; F:(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity; IDA:UniProtKB. DR GO; GO:0018812; F:3-hydroxyacyl-CoA dehydratase activity; EXP:UniProtKB. DR GO; GO:0008692; F:3-hydroxybutyryl-CoA epimerase activity; IEA:UniProtKB-EC. DR GO; GO:0004165; F:delta(3)-delta(2)-enoyl-CoA isomerase activity; IEA:UniProtKB-EC. DR GO; GO:0004300; F:enoyl-CoA hydratase activity; IDA:UniProtKB. DR GO; GO:0016509; F:long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity; IEA:RHEA. DR GO; GO:0070403; F:NAD+ binding; IEA:InterPro. DR GO; GO:0006635; P:fatty acid beta-oxidation; ISS:TAIR. DR GO; GO:0009908; P:flower development; IMP:TAIR. DR GO; GO:0009695; P:jasmonic acid biosynthetic process; IMP:UniProtKB. DR GO; GO:0009845; P:seed germination; IMP:TIGR. DR CDD; cd06558; crotonase-like; 1. DR FunFam; 3.40.50.720:FF:000009; Fatty oxidation complex, alpha subunit; 1. DR FunFam; 1.10.1040.50:FF:000004; Peroxisomal fatty acid beta-oxidation multifunctional protein; 1. DR FunFam; 3.90.226.10:FF:000025; Peroxisomal fatty acid beta-oxidation multifunctional protein; 1. DR Gene3D; 1.10.1040.50; -; 1. DR Gene3D; 3.90.226.10; 2-enoyl-CoA Hydratase, Chain A, domain 1; 1. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR InterPro; IPR006180; 3-OHacyl-CoA_DH_CS. DR InterPro; IPR006176; 3-OHacyl-CoA_DH_NAD-bd. DR InterPro; IPR006108; 3HC_DH_C. DR InterPro; IPR008927; 6-PGluconate_DH-like_C_sf. DR InterPro; IPR029045; ClpP/crotonase-like_dom_sf. DR InterPro; IPR018376; Enoyl-CoA_hyd/isom_CS. DR InterPro; IPR001753; Enoyl-CoA_hydra/iso. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR PANTHER; PTHR23309; 3-HYDROXYACYL-COA DEHYROGENASE; 1. DR PANTHER; PTHR23309:SF53; PEROXISOMAL FATTY ACID BETA-OXIDATION MULTIFUNCTIONAL PROTEIN AIM1; 1. DR Pfam; PF00725; 3HCDH; 1. DR Pfam; PF02737; 3HCDH_N; 1. DR Pfam; PF00378; ECH_1; 1. DR SUPFAM; SSF48179; 6-phosphogluconate dehydrogenase C-terminal domain-like; 2. DR SUPFAM; SSF52096; ClpP/crotonase; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. DR PROSITE; PS00067; 3HCDH; 1. DR PROSITE; PS00166; ENOYL_COA_HYDRATASE; 1. PE 1: Evidence at protein level; KW Fatty acid metabolism; Isomerase; Lipid metabolism; Lyase; KW Multifunctional enzyme; NAD; Oxidoreductase; Peroxisome; KW Reference proteome. FT CHAIN 1..721 FT /note="Peroxisomal fatty acid beta-oxidation FT multifunctional protein AIM1" FT /id="PRO_0000401372" FT MOTIF 719..721 FT /note="Microbody targeting signal" FT /evidence="ECO:0000305" FT ACT_SITE 116 FT /note="Nucleophile" FT /evidence="ECO:0000255" FT ACT_SITE 136 FT /note="Proton acceptor" FT /evidence="ECO:0000255" SQ SEQUENCE 721 AA; 77858 MW; F72FB3252B2216CF CRC64; MAKKIGVTME VGNDGVAVIT ISNPPVNSLA SPIISGLKEK FRDANQRNDV KAIVLIGNNG RFSGGFDINV FQQVHKTGDL SLMPEVSVEL VCNLMEDSRK PVVAAVEGLA LGGGLELAMA CHARVAAPKA QLGLPELTLG VIPGFGGTQR LPRLVGLAKA TDMILLSKSI SSEEGHKLGL IDALVPPGDV LSTSRKWALD IAEGRKPFLQ SLHRTDKIGS LSEARAILKN SRQLAKKIAP NMPQHHACIE VIEEGIIHGG YSGVLKEAEV FKQLVLSDTA KGLVHVFFAQ RATSKVPNVT DVGLKPRPIK KVAVIGGGLM GSGIATALLL SNIRVVLKEI NSEFLMKGIK SVEANMKSLV SRGKLTQDKA GKALSLFKGV LDYTEFNDVD MVIEAVIENI QLKQNIFKEI EKVCSPHCIL ASNTSTIDLD VIGEKTNSKD RIVGAHFFSP AHLMPLLEIV RSKNTSAQVI LDLMAVGKAI KKVPVVVGNC IGFAVNRTFF PYSQAAHMLA NLGVDLFRID SVITSFGLPL GPFQLGDLAG HGIGLAVGPI YAKVYGDRMF RSPMTELLLK SGRNGKINGR GYYIYEKGSK PKPDPSVLSI VEKSRKLTNI MPGGKPISVT DKEIVEMILF PVVNEACRVL DEGVVIRASD LDIASVLGMS FPSYRGGIVF WADTVGPKYI YERLKKLSET YGSFFKPSRY LEERAMNGML LSESKSSRSK L //